• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Artificial Heart Market

    ID: MRFR/HC/18036-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Artificial Heart Market Research Report By Type (Heart-Lung Machine, Mechanical Heart, Total Artificial Hearts, Ventricular Assist Devices (VADs)) and By End User (Hospitals & Clinics, Specialty Centers) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Artificial Heart Market Infographic
    Purchase Options

    US Artificial Heart Market Summary

    The United States Artificial Heart market is projected to grow significantly from 1.25 USD billion in 2024 to 6 USD billion by 2035.

    Key Market Trends & Highlights

    US Artificial Heart Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 15.33 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 6 USD billion, indicating robust growth potential.
    • The base year valuation for the market stands at 1.25 USD billion in 2024, reflecting a strong starting point for expansion.
    • Growing adoption of artificial heart technology due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.25 (USD Billion)
    2035 Market Size 6 (USD Billion)
    CAGR (2025-2035) 15.33%

    Major Players

    Medtronic, Abbott Laboratories, Boston Scientific, Terumo Cardiovascular Systems, LifeTech Scientific, Evaheart, St. Jude Medical, CardiacAssist, Carmat, Corphenex, CircuLite, Cleveland Clinic, SynCardia Systems, MediCure, AorTech International

    US Artificial Heart Market Trends

    The US Artificial Heart Market is witnessing significant trends driven by advancements in technology and increasing patient needs. One of the key market drivers is the rising prevalence of cardiovascular diseases, which is a leading cause of death in the United States. As the population ages and lifestyle-related ailments increase, more patients are looking for heart replacement options. Innovations in artificial heart technology, including improved design, biocompatibility, and miniaturization, are further driving market growth.

    Opportunities are emerging in the development of next-generation devices that promise enhanced functionality and longevity, catering not only to patients awaiting heart transplants but also to those who may not qualify for traditional surgery. Recently, there has been a growing focus on the integration of artificial hearts with digital health technologies, enabling better patient monitoring and data collection. This digital shift allows for real-time health management and personalized treatment plans, making artificial heart therapy more effective and accessible.

    Additionally, the rise of outpatient surgical procedures is transforming how patients receive artificial heart interventions, reducing hospital stays and costs involved with traditional methods. Various initiatives and support from healthcare organizations in the US aim to promote awareness of artificial heart options, which is fostering acceptance among both patients and healthcare professionals. Research into new materials and designs continues to expand, creating further opportunities for innovation in the US market. With the combination of advanced technology, a growing patient base, and supportive healthcare policies, the US Artificial Heart Market is poised for substantial growth in the coming years.

    Market Segment Insights

    Artificial Heart Market Type Insights

    The US Artificial Heart Market is diverse and segmented primarily by Type, revealing a comprehensive landscape characterized by significant advancements in medical technology. Within this segment, the Heart-Lung Machine is crucial for providing cardiac and respiratory support during surgeries, illustrating its essential role in complex procedures, particularly in cardiothoracic operations. Mechanical Hearts serve as a pivotal alternative for patients experiencing severe heart failure, acting as a temporary solution while patients await transplants, thereby addressing the shortage of available donor organs.

    Total Artificial Hearts represent a remarkable innovation that can replace the heart entirely, providing life-altering capabilities for patients with end-stage heart disease and illustrating advancements in device reliability and patient outcomes. Ventricular Assist Devices (VADs) have gained considerable traction as they assist heart function and blood flow in patients with weakened hearts, making them a vital component in heart failure management and supporting patients prior to and following heart transplantation. The growing prevalence of heart diseases in the US, coupled with advancements in surgical techniques and device technology, underscores the importance of each type within the market.

    Furthermore, increasing investment in Research and Development activities within the healthcare sector is poised to drive innovations in the artificial heart space, further bolstering the capabilities and efficacy of these devices. The overall aging population, combined with rising cardiovascular disorders, enhances the urgency for robust solutions encapsulated within these segment types. The integration of cutting-edge technology and data-driven healthcare approaches aligns with the evolving needs of patients and healthcare providers, reflecting robust potential in market growth.

    As such, each segment thrives under increasing focus on improving patient care, outcomes, and quality of life, establishing the US Artificial Heart Market as a multi-faceted and essential part of the broader healthcare environment.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Artificial Heart Market End User Insights

    The End User segment of the US Artificial Heart Market plays a vital role in accommodating the growing demand for artificial heart technologies, primarily through Hospitals and Clinics, as well as Specialty Centers. Hospitals and Clinics are significant hubs for cardiac care, providing essential procedures and follow-up services for patients with severe heart conditions. They typically have specialized personnel and technological capabilities to effectively manage complex heart procedures, which enhances patient outcomes and fosters technological advancements in artificial heart devices.

    Specialty Centers focus on treating specific heart conditions with tailored interventions, leading to improved diagnostic and therapeutic efficiency. They often attract patients who are seeking advanced treatment options, reinforcing their importance in the overall healthcare ecosystem. The collaborative nature of these End Users supports research and development initiatives, driving continuous innovations in artificial hearts. Additionally, the increasing prevalence of heart diseases in the US further emphasizes the relevance of these facilities, as they are crucial for delivering state-of-the-art care to a growing patient population.

    Overall, the strategic positioning of Hospitals and Clinics alongside Specialty Centers in the US Artificial Heart Market enables them to effectively meet the dynamic healthcare demands of patients with cardiac ailments.

    Get more detailed insights about US Artificial Heart Market

    Key Players and Competitive Insights

    The US Artificial Heart Market is characterized by intense competition among key players who are striving to innovate and improve their product offerings. As the prevalence of heart diseases continues to escalate, the demand for artificial hearts to treat severe cases of heart failure is rising. Various companies are focusing on research and development to create devices that enhance patient outcomes and address the limitations of existing technologies. The market landscape is influenced by several factors, including regulatory approvals, technological advancements, partnerships, and collaborations that companies pursue to stay ahead in the competitive scenario.

    With an increasing aging population and growing awareness about cardiovascular diseases, companies are continuously looking to capture market share through differentiated product strategies and effective marketing initiatives.

    Medtronic, a leading player in the US Artificial Heart Market, has established a significant presence due to its robust range of cardiovascular devices and solutions. The company is known for its innovative ventricular assist devices, which are crucial for patients who are not candidates for heart transplants or are awaiting transplantation. Medtronic's strengths lie in its comprehensive research and clinical programs aimed at validating the effectiveness of its products. The company’s commitment to advancing technology for cardiac support is evident in its continuous investment in R&D, helping to maintain a competitive edge.

    Additionally, Medtronic benefits from an extensive distribution network and collaborations with healthcare systems, which enable it to reach a wider patient base and enhance its market penetration across the United States.

    Abbott Laboratories is another formidable entity in the US Artificial Heart Market, recognized for its advancements in heart implant technologies. The company offers a variety of products like left ventricular assist devices and has made notable advancements in heart failure management. With a strong portfolio, Abbott Laboratories strengthens its position through its commitment to innovation and a focus on patient-centric solutions. The company has engaged in strategic mergers and acquisitions to amplify its capabilities and expand its technological reach within the cardiovascular sector.

    These initiatives have not only provided Abbott with enhanced expertise but have also produced synergies that bolster its market presence. The combination of a diverse product line, strong R&D focus, and strategic partnerships contributes to Abbott Laboratories' competitive strengths in the US Artificial Heart Market.

    Key Companies in the US Artificial Heart Market market include

    Industry Developments

    The US Artificial Heart Market has seen significant developments recently. In October 2023, Medtronic announced advancements in their cardiac devices, promising improved patient outcomes and extending the lifespan of artificial hearts. Abbott Laboratories continues to focus on innovation, recently unveiling new clinical data supporting their heart pump systems. Boston Scientific is also actively participating in clinical trials aimed at enhancing device efficiency and patient care.

    On the mergers and acquisitions front, Terumo Cardiovascular Systems officially acquired certain assets related to heart pump technology from a smaller firm in September 2023, enhancing their portfolio in this sector. The market valuation for companies like LifeTech Scientific and St. Jude Medical has shown growth due to rising demand for heart assist devices, bolstered by an increasing number of heart failure cases in the US. Moreover, the collaboration between Cleveland Clinic and SynCardia Systems in November 2022 has been pivotal in integrating advanced technology into cardiac care.

    These trends indicate a robust market environment driven by medical breakthroughs and strategic partnerships. Major developments in the last few years indicate a focus on patient-centered innovations and technological advancements in artificial hearts, critically impacting therapy options available in the US.

    Market Segmentation

    Artificial Heart Market Type Outlook

    • Heart-Lung Machine
    • Mechanical Heart
    • Total Artificial Hearts
    • Ventricular Assist Devices (VADs)

    Artificial Heart Market End User Outlook

    • Hospitals & Clinics
    • Specialty Centers

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 1.05(USD Billion)
    MARKET SIZE 2024 1.25(USD Billion)
    MARKET SIZE 2035 6.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 15.327% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Medtronic, Abbott Laboratories, Boston Scientific, Terumo Cardiovascular Systems, LifeTech Scientific, Evaheart, St. Jude Medical, CardiacAssist, Carmat, Corphenex, CircuLite, Cleveland Clinic, SynCardia Systems, MediCure, AorTech International
    SEGMENTS COVERED Type, End User
    KEY MARKET OPPORTUNITIES Rising prevalence of heart diseases, Technological advancements in devices, Increasing aging population, Growing demand for transplant alternatives, Expanding reimbursement policies for artificial hearts
    KEY MARKET DYNAMICS Aging population, Rising cardiovascular diseases, Technological advancements, Increasing healthcare expenditure, Regulatory approvals and innovations
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Artificial Heart Market in 2024?

    The US Artificial Heart Market is expected to be valued at 1.25 billion USD in 2024.

    What will the market size of the US Artificial Heart Market be by 2035?

    By 2035, the US Artificial Heart Market is projected to reach 6.0 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Artificial Heart Market from 2025 to 2035?

    The expected CAGR for the US Artificial Heart Market from 2025 to 2035 is 15.327 percent.

    Which segment of the US Artificial Heart Market is projected to have the largest market size by 2035?

    By 2035, Ventricular Assist Devices (VADs) are projected to be the largest segment, valued at 2.25 billion USD.

    Who are the major players in the US Artificial Heart Market?

    Key players in the US Artificial Heart Market include Medtronic, Abbott Laboratories, and Boston Scientific among others.

    What market value is attributed to the Mechanical Heart segment in 2024?

    The Mechanical Heart segment is expected to have a market value of 0.3 billion USD in 2024.

    What trends are driving growth in the US Artificial Heart Market?

    Growing prevalence of cardiac diseases and technological advancements are key growth drivers in the market.

    How much is the Total Artificial Hearts segment expected to be valued in 2035?

    The Total Artificial Hearts segment is expected to reach a value of 1.0 billion USD by 2035.

    What is the projected market size for the Heart-Lung Machine segment by 2035?

    The Heart-Lung Machine segment is projected to be valued at 1.25 billion USD by 2035.

    What challenges are currently facing the US Artificial Heart Market?

    Challenges such as high costs and regulatory hurdles are currently impacting the US Artificial Heart Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials